Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions

被引:19
|
作者
Verity, Erin E.
Zotos, Dimitra
Wilson, Kim
Chatfield, Catherine
Lawson, Victoria A.
Dwyer, Dominic E.
Cunningham, Anthony
Learmont, Jennifer
Dyer, Wayne
Sullivan, John
Churchill, Melissa
Wesselingh, Steven L.
Gabuzda, Dana
Gorry, Paul R.
McPhee, Dale A.
机构
[1] St Vincents Inst Med Res, Natl Serol Reference Lab, Fitzroy, Vic 3065, Australia
[2] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia
[3] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia
[4] Deakin Univ, Sch Biol & Chem Sci, Burwood, Vic, Australia
[5] Westmead Millenium Inst, Ctr Virus Res, Westmead, NSW, Australia
[6] Australian Red Cross Blood Serv, Sydney, NSW, Australia
[7] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[8] Dana Farber Canc Inst, Boston, MA 02115 USA
[9] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
关键词
D O I
10.1128/JVI.00650-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Sydney Blood Bank Cohort (SBBC) consists of eight blood transfusion recipients infected with nef-attenuated human immunodeficiency virus type 1 (HIV-1) acquired from a single donor. Here, we show that viral phenotypes and antibody responses differ considerably between individual cohort members, despite the single source of infection. Replication of isolated virus varied from barely detectable to similar to that of the wild-type virus, and virus isolated from five SBBC members showed coreceptor usage signatures unique to each individual. Higher viral loads and stronger neutralizing antibody responses were associated with better-replicating viral strains, and detectable viral replication was essential for the development of strong and sustained humoral immune responses. Despite the presence of strong neutralizing antibodies in a number of SBBC members, disease progression was not prevented, and each cohort member studied displayed a unique outcome of infection with nef-attenuated HIV-1.
引用
收藏
页码:9268 / 9278
页数:11
相关论文
共 50 条
  • [41] ANALYSIS OF LONG TERMINAL REPEAT CIRCLE JUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SMITH, JS
    KIM, SY
    ROTH, MJ
    JOURNAL OF VIROLOGY, 1990, 64 (12) : 6286 - 6290
  • [42] Human Immunodeficiency Virus Type 1 Two-Long Terminal Repeat Circles: A Subject for Debate
    Olivares, Isabel
    Pernas, Maria
    Casado, Concepcion
    Lopez-Galindez, Cecilio
    AIDS REVIEWS, 2016, 18 (01) : 23 - 31
  • [43] ANALYSIS OF NATURAL VARIATION IN THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GEELEN, JLMC
    KOKEN, SEC
    VANWAMEL, J
    BOUCHER, CAB
    GOUDSMIT, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 322 - 322
  • [44] Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression
    Mehta, Roshni
    Sundaravaradan, Vasudha
    Ahmad, Nafees
    VIROLOGY, 2008, 375 (01) : 170 - 181
  • [45] Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine
    Jankelevich, S
    Mueller, BU
    Mackall, CL
    Smith, S
    Zwerski, S
    Wood, LV
    Zeichner, SL
    Serchuck, L
    Steinberg, SM
    Nelson, RP
    Sleasman, JW
    Nguyen, BY
    Pizzo, PA
    Yarchoan, R
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07): : 1116 - 1120
  • [46] LONG-TERM OBSERVATIONS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHIMPANZEES
    JOHNSON, BK
    STONE, GA
    GODEC, MS
    ASHER, DM
    GAJDUSEK, DC
    GIBBS, CJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (04) : 375 - 378
  • [47] Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir
    Kolber, MA
    Saenz, MO
    Kaul, S
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (01) : 76 - 80
  • [48] The kappa B sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth
    Chen, BK
    Feinberg, MB
    Baltimore, D
    JOURNAL OF VIROLOGY, 1997, 71 (07) : 5495 - 5504
  • [49] Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
    Pilgrim, AK
    Pantaleo, G
    Cohen, OJ
    Fink, LM
    Zhou, JY
    Zhou, JT
    Bolognesi, DP
    Fauci, AS
    Montefiori, DC
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04): : 924 - 932
  • [50] Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors
    Rusconi, S
    Berlusconi, A
    Papagno, L
    Colombo, MC
    deMaddalena, C
    Riva, A
    Bagnarelli, P
    Balotta, C
    Galli, M
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (03): : 320 - 323